使用罗4D-AlzNet和转移学习来识别阿尔茨海默病的阶段
Atif Mehmood1, Farah Shahid1, Rizwan Khan2
1School of Computer Science and Technology, Zhejiang Normal University, Jinhua 321004, China; Zhejiang Institute of Photoelectronics & Zhejiang Institute for Advanced Light Source, Zhejiang Normal University, Jinhua, Zhejiang 321004, China.
Neuroscience
|March 16, 2024
概括
这项研究介绍了Siamese 4D-AlzNet,这是一种用于使用MRI扫描进行早期阿尔茨海默病 (AD) 检测的AI模型. 该模型在区分AD与正常认知方面达到95%以上的准确性,提高了诊断能力.
科学领域:
- 神经科学是一个神经科学.
- 医疗成像医学成像
- 人工智能的人工智能
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经系统疾病,导致痴呆和记忆丧失.
- 早期发现AD对于患者的管理和治疗至关重要.
- 人工智能 (AI) 和深度学习 (DL) 在自动化从医疗图像中检测AD方面表现有前途.
研究的目的:
- 开发和评估用于早期发现和分类阿尔茨海默病的自动化AI模型.
- 通过使用T1加权MRI图像来提高AD诊断的准确性和效率.
- 解决当前方法关于抽象特征提取和有限的注释数据的局限性.
主要方法:
- 提出了一个新语4D-AlzNet模型,整合了四个并行的卷积神经网络 (CNN) 流.
- 使用VGG-19,VGG-16和AlexNet架构的定制转移学习.
- 使用T1加权的MRI扫描从四个主体类别:正常控制 (NC),轻度认知障碍 (MCI),晚期轻度认知障碍 (LMCI) 和AD.
主要成果:
- 在区分正常控制 (NC) 和阿尔茨海默病 (AD) 患者之间取得了惊人的95.05%的准确性.
- 对于其他二进制类比较 (例如,MCI-AD) 证明一致的准确性超过90%.
- 性能优于最新的最先进方法,NC-AD和MCI-AD分类准确度分别提高了2%和7%.
结论:
- 罗4D-AlzNet模型显示出对精确和自动化的阿尔茨海默病早期检测有很大的潜力.
- 提出的方法有效地捕获抽象级信息,克服了以前技术的局限性.
- 这种人工智能驱动的方法为放射科医生和临床医生提供了一种有价值的工具,有可能节省AD诊断的时间和成本.
相关概念视频
01:26Alzheimer's Disease: Overview
475
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
475
01:22Alzheimer's Disease: Treatment
186
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
186
01:30Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113